Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
ConditionKeratoconus
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age13+
SponsorGlaukos Corporation
About this trial
Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.
Eligibility criteria
Qualifiers
Provide written informed consent
Willing and able to comply with study instructions and follow-up visits
Diagnosis of keratoconus in each eye
Disqualifiers
Known allergy or sensitivity to study medications
History of corneal disease
Prior corneal cross-linking in either eye
Pregnant, nursing, or planning pregnancy during the study period
Trial design
Treatments tested in this trial
- Riboflavin Ophthalmic Solutions
- UV-A Irradiation System
Treatment groups
15 Participants
are divided into 1 treatment groupLocations
1Glaukos Investigative Site43082, WestervilleOhio, United States
Sponsors and collaborators
Glaukos Corporation
Lead sponsor
Source ClinicalTrials.gov